MyAverix Finance
US · Healthcare
Kiromic Biopharma Inc (KRBP)
Biotechnology
Kiromic Biopharma Inc (KRBP) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $214,931, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for KRBP
Kiromic Biopharma Inc (KRBP) — FAQ
What is Kiromic Biopharma Inc's market cap?
Kiromic Biopharma Inc (KRBP) has a reported market cap of $214,931 (data as of 2026-03-30).
What is KRBP's P/E ratio?
The price-to-earnings (P/E) ratio for Kiromic Biopharma Inc (KRBP) is 18.00 (data as of 2026-03-30).
Does Kiromic Biopharma Inc pay a dividend?
Dividend yield is not available in the current snapshot for Kiromic Biopharma Inc (KRBP). Check the MyAverix Finance app for the latest dividend data.
What sector is Kiromic Biopharma Inc in?
Kiromic Biopharma Inc (KRBP) is classified in the Healthcare sector (Biotechnology industry).
What exchange is KRBP listed on?
KRBP is listed on US.
What is Kiromic Biopharma Inc's net margin?
Kiromic Biopharma Inc (KRBP) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.